Early access
Sign in
CompletedNo phase

Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices

Key facts

Who runs it
ECOG-ACRIN Cancer Research Group
Where
Anchorage, Appleton, Atlanta, Auburn, Augusta, Belpre, Cedar Rapids, Danville, Des Moines, Easley, Fridley, Gastonia, Gig Harbor, Green Bay, Greenville, Greer, Hendersonville, Joplin, Marietta, Marion, Memphis, Mount Vernon, Oconto Falls, Portsmouth, Puyallup, Saint Joseph, Seneca, Sheboygan, Southhaven, Spartanburg, Springfield, Sturgeon Bay, Tacoma, The Bronx, and Urbana, United StatesSee the 42 sites
Trial code
Status
Completed
People taking part
306 people enrolled
Started
1 Aug 2019
Ended
31 Dec 2023
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Behavioral, Psychological or Informational Intervention
  • Nicotine Replacement
  • Quality-of-Life Assessment
  • Survey Administration
  • Tobacco Cessation Counseling
Record updated
18 March 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • STAFF ELIGIBILITY CRITERIA:
  • Must be English speaking
  • Must be employed at NCI Community Oncology Research Program (NCORP) site for at least three months
  • PATIENT ELIGIBILITY CRITERIA STEP 0:
  • Patient presenting with any type of cancer with a date of diagnosis within the past 4 months. Recurrence, diagnosed within the last 4 months, of tumors in patients with past cancer diagnoses will be considered eligible. Patients with a new primary cancer, diagnosed within the last 4 months, who have been treated previously for other types of cancer will also be considered eligible. ?In situ? cancers, diagnosed within the past 4 months, will also be considered eligible
  • Patient must be a current smoker. Current smoker is defined as any cigarette smoking (even a puff) in the past 30 days
  • Patient must be fluent in both, written and spoken, English or both, written and spoken, Spanish
  • Patient must have telephone, e-mail access, and have access to the internet with a camera-enabled device (e.g., smartphone, tablet, computer, laptop with a webcam/camera); NOTE: The restriction to those with web and e-mail access is based on the primary intention of the study; to assess the implementation of the virtual intervention in the NCORP network
  • ELIGIBILITY CRITERIA STEP 1: Patient must still meet all criteria outlined in step 0
  • ELIGIBILITY STEP 2 (RANDOMIZATION): Patient must have completed baseline survey in Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) Cancer Research Group Systems for Easy Entry of Patient Reported Outcomes (EASEEPRO) within 1 month (30 days) of the date of informed consent (Step 1)

Who cannot take part

  • Patient has no intention to receive their cancer care or monitoring at an NCORP community cancer site
  • Patient has an Eastern Cooperative Oncology Group (ECOG) performance status of 3 or above, or is deemed medically unable to participate by study investigators or oncology clinician (i.e., referral to hospice)

Where in United States

  • Alaska Women's Cancer CareAnchorage, United States
  • Katmai Oncology GroupAnchorage, United States
  • ThedaCare Regional Cancer CenterAppleton, United States
  • Northside HospitalAtlanta, United States
  • MultiCare Auburn Medical CenterAuburn, United States
  • Augusta University Medical CenterAugusta, United States
  • Strecker Cancer Center-BelpreBelpre, United States
  • Physicians' Clinic of Iowa PCCedar Rapids, United States
  • Carle on VermilionDanville, United States
  • Iowa Methodist Medical CenterDes Moines, United States
  • Medical Oncology and Hematology Associates-Des MoinesDes Moines, United States
  • Prisma Health Cancer Institute - EasleyEasley, United States
  • Unity HospitalFridley, United States
  • CaroMont Regional Medical CenterGastonia, United States
  • MultiCare Gig Harbor Medical ParkGig Harbor, United States
  • Aurora BayCare Medical CenterGreen Bay, United States
  • Saint Vincent Hospital Cancer Center at Saint Mary'sGreen Bay, United States
  • Saint Vincent Hospital Cancer Center Green BayGreen Bay, United States
  • Prisma Health Cancer Institute - ButternutGreenville, United States
  • Prisma Health Cancer Institute - EastsideGreenville, United States
  • Prisma Health Cancer Institute - FarisGreenville, United States
  • Prisma Health Cancer Institute - GreerGreer, United States
  • Margaret R Pardee Memorial HospitalHendersonville, United States
  • Freeman Health SystemJoplin, United States
  • Marietta Memorial HospitalMarietta, United States
  • OhioHealth Marion General HospitalMarion, United States
  • Baptist Memorial Hospital and Cancer Center-MemphisMemphis, United States
  • Baptist Memorial Hospital for WomenMemphis, United States
  • Good Samaritan Regional Health CenterMount Vernon, United States
  • Saint Vincent Hospital Cancer Center at Oconto FallsOconto Falls, United States
  • Southern Ohio Medical CenterPortsmouth, United States
  • MultiCare Good Samaritan HospitalPuyallup, United States
  • Heartland Regional Medical CenterSaint Joseph, United States
  • Prisma Health Cancer Institute - SenecaSeneca, United States
  • HSHS Saint Nicholas HospitalSheboygan, United States
  • Baptist Memorial Hospital and Cancer Center-DesotoSouthhaven, United States
  • Prisma Health Cancer Institute - SpartanburgSpartanburg, United States
  • CoxHealth South HospitalSpringfield, United States
  • Saint Vincent Hospital Cancer Center at Sturgeon BaySturgeon Bay, United States
  • MultiCare Tacoma General HospitalTacoma, United States
  • Montefiore Medical Center - Moses CampusThe Bronx, United States
  • Carle Cancer CenterUrbana, United States

About the trial

What the trial wants to find out

This phase II trial studies how well smoking cessation treatment plans work in tobacco-dependent cancer patients when delivered virtually as part of their cancer care in community oncology practices. Virtual information and counseling sessions may help cancer patients quit smoking.

The 2 groups in the trial

  • Arm A (smoking assessment, quitting advice, Quitline referral)Existing treatment, for comparison

    Patients receive an assessment of smoking status and provision of quitting advice through the screening and referral process, and are referred to the NCI Smoking Quitline.

    Treatment: Behavioral, Psychological or Informational Intervention and Quality-of-Life Assessment

  • Arm B (virtual counseling sessions, NRT)Treatment being tested

    Patients receive an initial virtual counseling session with a study-designated tobacco treatment coach via MGH TeleHealth over 40 minutes and up to 10 more virtual counseling sessions over 15 minutes for approximately 6 months. Patients also receive up to 12 weeks of NRT (patch and lozenge combined or alone).

    Treatment: Nicotine Replacement, Quality-of-Life Assessment, Survey Administration, and Tobacco Cessation Counseling

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Implementing a Virtual Tobacco Treatment in Community Oncology Practices: "Smoke Free Support Study 2.0"
Publications
Record updated
18 March 2025